Patient
SITE005-0074
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2025-11-17
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-07-05
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-29 (study day 212); relationship: not assessed
mild
assessed
2026-03-03
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-08-27 (study day 88); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.